Serina Therapeutics Inc (SER)
NYSEAMERICAN: SER · IEX Real-Time Price · USD
13.46
-1.41 (-9.49%)
Mar 28, 2024, 3:45 PM EDT - Market closed

Serina Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 20232022202120202019201820172016
Cash & Equivalents
0.40.70.630.532.356.717.380.26
Cash & Cash Equivalents
0.40.70.630.532.356.717.380.26
Cash Growth
-43.17%9.62%20.30%-77.59%-64.93%-9.06%2747.49%-
Receivables
0.0600.030.330.360.130.110.31
Other Current Assets
0.31.751.581.431.341.020.110.12
Total Current Assets
0.752.452.232.284.057.857.590.69
Property, Plant & Equipment
00001.130.090.130.2
Long-Term Investments
10.550000000
Goodwill and Intangibles
0.610.740.871.592.152.711.872.3
Other Long-Term Assets
0.050.050.050.050.110.020.040.04
Total Long-Term Assets
11.210.790.921.643.392.822.042.54
Total Assets
11.973.243.153.937.4410.679.633.22
Accounts Payable
2.241.180.841.731.651.50.9825.25
Deferred Revenue
0000.340.280.320.180.26
Current Debt
3.677.657.142.40.43000
Other Current Liabilities
01.260.990.90.940.630.150.08
Total Current Liabilities
5.9110.088.975.363.32.441.3125.6
Long-Term Debt
0.6910.486.063.91.53000
Other Long-Term Liabilities
0000.060000
Total Long-Term Liabilities
0.6910.486.063.961.53000
Total Liabilities
6.6120.5615.039.324.832.441.3125.6
Total Debt
4.3718.1213.26.31.96000
Debt Growth
-75.92%37.28%109.69%221.88%----
Retained Earnings
-131.01-116.21-105.75-97.07-86.21-74.05-66.55-59.97
Comprehensive Income
0000.140.07-00.070.06
Shareholders' Equity
5.47-17.21-11.83-5.122.227.457.28-23.42
Net Cash / Debt
-3.97-17.43-12.57-5.770.46.717.380.26
Net Cash / Debt Growth
-----94.10%-9.06%2747.49%-
Net Cash Per Share
-3.68-16.15-11.67-5.390.376.768.460.32
Working Capital
-5.16-7.63-6.73-3.070.765.416.28-24.91
Book Value Per Share
5.07-15.95-10.98-4.782.097.508.36-28.60
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).